Imprimis NJOF, LLC is recalling 2,822 bottles of a sterile eye drop solution containing Tropicamide, Proparacaine, Phenylephrine, and Ketorolac. The recall was issued because a stability batch tested as "sub-potent," meaning the medication is weaker than the concentration required by product specifications. If the drug is not at the correct strength, it may not work as intended during medical procedures or treatment.
Using a sub-potent medication can lead to reduced effectiveness, which may result in inadequate pupil dilation or insufficient pain management during ophthalmic procedures. No injuries or adverse events have been reported to date in connection with this recall.
You have 2 options:
Quantity: 2822 bottles affected. Distributed in FL and NY.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.